AI assistant
Sending…
ORTHOPEDIATRICS CORP — Director's Dealing 2023
Apr 26, 2023
32906_dirs_2023-04-26_207f17e7-5fb5-4efb-a1c0-2dd7f8b4a46d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2023-04-25
Reporting Person: Odle Gregory A (President of Scoliosis)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-25 | Common Stock | S | 828 | $50.0237 | Disposed | 86574 | Direct |
Footnotes
F1: Shares sold pursuant to a 10b5-1 plan.
F2: Includes restricted stock awards totaling 37,910 shares.
More from ORTHOPEDIATRICS CORP
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 20
Capital/Financing Update
2026
Apr 1
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Investor Presentation
2026
Feb 26